Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - potassium bicarbonate; sodium alginate - chewable tablet - 100mg ; 500mg

Kenia - Englisch - Pharmacy and Poisons Board

pine healthcare limited pine healthcare limited - sodium bicarbonate, sodium alginate and calcium… - concentrate for oral suspension - sodium bicarbonate 133.5mg/5ml, sodium alginate… - antacids with sodium bicarbonate

Kenia - Englisch - Pharmacy and Poisons Board

beta healthcare international limited plot no. l.r 209/6554 mogadishu road, industrial - sodium alginate and sodium bicarbonate - oral suspension - each 10ml contains sodium alginate 500mg and… - antacids with sodium bicarbonate

Kenia - Englisch - Pharmacy and Poisons Board

sodium alginate,sodium bicarbonate - oral suspension - sodium alginate 500mg,sodium bicarbonate 267mg - alginic acid

Malta - Englisch - Medicines Authority

charles de giorgio limited triq il-kanonku, karmenu pirotta, birkirkara bkr 1114, malta - sodium alginate, potassium bicarbonate - chewable tablet - sodium alginate 500 mg potassium bicarbonate 100 mg - drugs for acid related disorders

Kanada - Englisch - Health Canada

pharmascience inc - valproic acid (divalproex sodium) - tablet (enteric-coated) - 250mg - valproic acid (divalproex sodium) 250mg - miscellaneous anticonvulsants

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

rebel distributors corp - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 50 mg - carefully consider the potential benefits and risks of diclofenac sodium delayed-release and other treatment options before deciding to use diclofenac sodium delayed-release. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). diclofenac sodium delayed-release tablets are indicated: • for relief of signs and symptoms of osteoarthritis • for relief of signs and symptoms of rheumatoid arthritis • for acute or long-term use in the relief of signs and symptoms of ankylosing spondylitis diclofenac sodium delayed-release tablets are contraindicated in patients with known hypersensitivity to diclofenac. diclofenac sodium delayed-release should not be given to patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic-like reactions to nsaids have been reported in such patients (see warnings, anaphylactoid reactions, and precautions, preexisting asthma)

Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

lloyds pharmacy ltd - sodium alginate; calcium carbonate; sodium bicarbonate - oral suspension - 50mg/1ml ; 16mg/1ml ; 26.7mg/1ml

Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

forum health products ltd - potassium bicarbonate; sodium alginate - chewable tablet - 100mg ; 500mg

Vereinigtes Königreich - Englisch - MHRA (Medicines & Healthcare Products Regulatory Agency)

reckitt benckiser healthcare (uk) ltd - calcium carbonate; sodium bicarbonate; sodium alginate - oral suspension - 32.5mg/1ml ; 21.3mg/1ml ; 50mg/1ml